The GLP is committed to full transparency. Download and review our 2019 Annual Report

Alzhiemer’s could be triggered by ‘genomic mosaicism’

| | January 25, 2019
hands holding
Image credit: Edward Shaw
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Certain inherited genetic mutations lead to Alzheimer’s disease (AD), but they are relatively rare. A recent study from my laboratory, however, shows that gene alterations that are not passed along by one’s parents may also play a key role in triggering the disease. This happens as a result of a process that occurs in the cell nucleus, known as gene recombination (GR), which can make changes to the DNA “blueprint” in human neurons.

We discovered that DNA sequences vary from cell to cell, meaning that our brains are a vast mosaic of distinct genomes, a phenomenon aptly referred to as “genomic mosaicism.”

Taking all this into account led us to conduct studies assessing mosaicism in AD brains. Our findings showed greater mosaicism—in particular, for increased [amyloid precursor protein] copy numbers. Most notably, segments of DNA in the APP gene were found to not only be amplified in some neurons. But certain APP segments increased in number more than others, hinting at GR.

Related article:  After another failed clinical trial, new Alzheimer’s treatment attacks disease from ‘different angle’

In principle, FDA-approved medications such as reverse-transcriptase inhibitors could be used today and may have special benefit for people in high-risk categories for whom no effective treatments currently exist. GR affecting different genes may underlie one or more of hundreds of other brain diseases and might also affect other cell types beyond the brain.

Read full, original post: A New Idea about What Triggers Alzheimer’s

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend